CLIA-tested genetic variants on commercial SNP arrays: Potential for incidental findings in genome-wide association studies

Genetics in Medicine

Volumn 12, Issue 6, 2010, Pages 355-363

  Johnson, Andrew D ^a,b   Bhimavarapu, Anupama ^a,b   Benjamin, Emelia J ^a,c   Fox, Caroline ^a,b   Levy, Daniel ^a,b,c   Jarvik, Gail P ^d   O'Donnell, Christopher J ^a,b,e  

^a FRAMINGHAM HEART STUDY   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c BOSTON UNIVERSITY   (United States)

^d UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

genetic; GWAS; incidental finding; return of results; SNP

Indexed keywords

APOLIPOPROTEIN E; BLOOD CLOTTING FACTOR 5 LEIDEN; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; STEROID 21 MONOOXYGENASE;

ALZHEIMER DISEASE; ARTICLE; BIOTINIDASE DEFICIENCY; FAMILIAL MEDITERRANEAN FEVER; GALACTOSEMIA; GENE MUTATION; GENETIC SCREENING; GENETIC VARIABILITY; HEMOCHROMATOSIS; HOMOZYGOTE; HUMAN; INCIDENTAL FINDING; MAJOR CLINICAL STUDY; PANCREATITIS; SICKLE CELL ANEMIA; SINGLE NUCLEOTIDE POLYMORPHISM; STEROID 21 MONOOXYGENASE DEFICIENCY; THROMBOPHILIA;

CLINICAL LABORATORY INFORMATION SYSTEMS; COMPUTATIONAL BIOLOGY; DATABASES, GENETIC; GENE EXPRESSION PROFILING; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; HAPLOTYPES; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; TUMOR MARKERS, BIOLOGICAL;

EID: 77953958784     PISSN: 10983600     EISSN: None     Source Type: Journal    
DOI: 10.1097/GIM.0b013e3181e1e2a9     Document Type: Article

References (37)

1. Lander ES, Linton LM, Birren B, et al; International Human Genome Sequencing Consortium. Initial sequencing and analysis of the human genome. Nature. 2001. 409. 860-921.
2. International HapMap Consortium; Frazer KA, Ballinger DG, Cox DR, et al. A second generation human haplotype map of 3.1 million SNPs. Nature 2007;449:851-861.
3. Johnson AD, O'Donnell CJ. An open access database of genome-wide association results. BMC Med Genet 2009;10:6.
4. Kohane IS, Masys DR, Altman RB. The incidentalome: a threat to genomic medicine. J Am Med Assoc 2006;296:212-215.
5. Wolf SM, Lawrenz FP, Nelson CA, et al. Managing incidental findings in human subjects research: analysis and recommendations. J Law Med Ethics 2008;36:219-248.
6. Bookman EB, Langehorne AA, Eckfeldt JH, et al; NHLBI Working Group. Reporting genetic results in research studies: summary and recommendations of an NHLBI working group. Am J Med Genet A 2006;140:1033-1040.
7. Hoeyer K, Olofsson BO, Mjorndal T, Lynoe N. Informed consent and biobanks: a population-based study of attitudes towards tissue donation for genetic research. Scand J Public Health 2004;32:224-229.
8. Hoeyer K. Donors perceptions of consent to and feedback from biobank research: time to acknowledge diversity? [Published online ahead of print November 26, 2009.] Public Health Genomics.
9. Hudson KL, Holohan MK, Collins FS. Keeping pace with the times\the Genetic Information Nondiscrimination Act of 2008. N Engl J Med 2008; 358:2661-2663.
10. Evans JP, Green RC. Direct to consumer genetic testing: avoiding a culture war. Genet Med 2009;11:568-569.
11. Johnson AD, Handsaker RE, Pulit SL, Nizzari MM, O'Donnell CJ, de Bakker PI. SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics 2008;24:2938-2939.
12. Johnson AD. Single-nucleotide polymorphism bioinformatics: a comprehensive review of resources. Circ Cardiovasc Genet 2009;2:530-536.
13. Dawber TR, Kannel WB, Lyell LP. An approach to longitudinal studies in a community: the Framingham Study. Ann N Y Acad Sci 1963;107:539-556.
14. Kannel WB, Feinleib M, McNamara PM, Garrison RJ, Castelli WP. An investigation of coronary heart disease in families. The Framingham offspring study. Am J Epidemiol 1979;110:281-290.
15. Splansky GL, Corey D, Yang Q, et al. The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: design, recruitment, and initial examination. Am J Epidemiol 2007;165:1328-1335.
16. Li Y, Abecasis G. MACH 1.0: rapid haplotype reconstruction and missing genotype inference. Am J Hum Genet 2006;S79:2290.
17. Cohen AF, Sedel F, Papo T. Cystathionine betasynthase and MTHFR deficiencies in adults. Rev Neurol (Paris) 2007;163:904-910.
18. Hirono A, Kawate K, Honda A, Fujii H, Miwa S. A single mutation 202GA in the human glucose-6-phosphate dehydrogenase gene (G6PD) can cause acute hemolysis by itself. Blood 2002;99:1498.
19. Town M, Bautista JM, Mason PJ, Luzzatto L. Both mutations in G6PD A-are necessary to produce the G6PD deficient phenotype. Hum Mol Genet 1992;1:171-174.
20. Askentijevich I, Torosyan Y, Samuels J, et al. Mutation and haplotype studies in familial Mediterranean fever reveal new ancestral relationships and evidence for a high carrier frequency with reduced penetrance in the Ashkenazi Jewish population. Am J Hum Genet 1999;64:949-962.
21. Cazeneuve C, Sarkisian T, Pecheux C, et al. MEFV-gene analysis in Armenian patients with familial Mediterranean fever: diagnostic value and unfavorable renal prognosis of the M694V homozygous genotype\genetic and therapeutic implications. Am J Hum Genet 1999; 65:88-97.
22. Touitou I. The spectrum of familial Mediterranean fever (FMF) mutations. Eur J Hum Genet 2001;9:473-483.
23. Sarkisian T, Ajrapetian H, Beglarian A, Shahsuvarian G, Egiazarian A. Familial Mediterranean Fever in Armenian population. Georgian Med News 2008;156:105-111.
24. Robins T, Barbaro M, Lajic S, Wedell A. Not all amino acid substitutions of the common cluster E6 mutation in CYP21 cause congenital adrenal hyperplasia. J Clin Endocrinol Metab 2005;90:2148-2153.
25. O'Reilly DA, Witt H, Rahman SH, et al. The SPINK1 N34S variant is associated with acute pancreatitis. Eur J Gastroenterol Hepatol 2008;20:726-731.
26. Rosendahl J, Bodeker H, Mossner J, Teich N. Hereditary chronic pancreatitis. Orphanet J Rare Dis 2007;2:1-10.
27. Ho WK, Hankey GJ, Quinlan DJ, Eikelboorn JW. Risk of recurrent venous thromboembolism in patients with common thrombophilia: a systematic review. Arch Intern Med 2006;166:729-736.
28. Press RD, Bauer KA, Kujovich JL, Heit JA. Clinical utility of factor V leiden (R506Q) testing for the diagnosis and management of thromboem-bolic disorders. Arch Pathol Lab Med 2002;126:1304-1318.
29. Ridker PM, Goldhaber SZ, Danielson E, et al; PREVENT Investigators. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. N Engl J Med 2003;348:1425-1434.
30. Adams PC, Reboussin DM, Barton JC, et al; Hemochromatosis and Iron Overload Screening (HEIRS) Study Research Investigators. Hemochroma-tosis and iron-overload screening in a racially diverse population. N Engl J Med 2005;352:1769-1778.
31. Niederau C, Fischer R, Purschel A, Stremmel W, Häussinger D, Strohm-eyer G. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 1996;110:1107-1119.
32. King C, Barton DE. Best practice guidelines for the molecular genetic diagnosis of Type I (HFE-related) hereditary hemochromatosis. BMC Med Genet 2006;7:81.
33. Cho MK. Understanding incidental findings in the context of genetics and genomics. J Law Med Ethics 2008;36:280-285.
34. Van Ness B. Genomic research and incidental findings. J Law Med Ethics 2008;36:292-297.
35. Janssens AC, Gwinn M, Bradley LA, Oostra BA, van Duijn CM, Khoury MJ. A critical appraisal of the scientific basis of commercial genomic profiles used to assess health risks and personalize health interventions. Am J Hum Genet 2008;82:593-599.
36. Bojesen A, Juul S, Gravholt CH. Prenatal and postnatal prevalence of Klinefelter syndrome: a national registry study. J Clin Endocrinol Metab 2003;88:622-626.
37. Manolio TA, Brooks LD, Collins FS. A HapMap harvest of insights into the genetics of common disease. J Clin Invest 2008;118:1590-1605.